1 / 27

Intrauterine Growth Restriction IUGR

Intrauterine Growth Restriction IUGR. Normal Intrauterine Growth. - Stage I growth inhibition Fewer cells but normal size - weight, head, length all < 10th percentile. Perinatal problems? Higher Lower Growth potential? Higher Lower. Symmetric. - Stage II/III growth inhibition

mildredmartin
Download Presentation

Intrauterine Growth Restriction IUGR

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Intrauterine Growth RestrictionIUGR

  2. Normal Intrauterine Growth

  3. - Stage I growth inhibition Fewer cells but normal size - weight, head, length all < 10th percentile Perinatal problems? Higher Lower Growth potential? Higher Lower Symmetric

  4. - Stage II/III growth inhibition Decrease in cell size, less effect on total cell number - weight below 10th percentile,head and length preserved Perinatal problems? Higher Lower Growth potential? Higher Lower Asymmetric

  5. Sex term males 150 gm heavier and 0.9 cm longer than females Parity 1st born infants smaller effect loss after 3rd birth Race, ethnicity, nationality Altitude Denver population growth curves under estimate weights of infants born at sea level Maternal size maternal pre-pregnancy weight and pregnancy weight gain correlate with fetus size What factors affect fetal weight?

  6. Number of fetuses Reduced rate of fetal growth of multiples Small breed embryo transplanted into large breed uterus will grow larger “Maternal constraint”- non-genetic

  7. Insulin Major hormone for in utero growth Produced by fetus Promotes fetal adipose deposition, glycogen stores Hormonal Factors

  8. Etiology- Overlapping Maternal, Fetal, Placenta • Maternal factors • Medical disease (US) • Malnutrition (world-wide) • Multiple pregnancy • Drugs • Hypoxemia • Small stature/ low pre-pregnancy weight • Teen pregnancy • Low SES • Prima gravida • Grand multiparity

  9. Fetal • Genetic • Congenital malformations • Genetic/ chromosomal (trisomies, syndromes) • Cardiovascular disease • Congenital infection • Inborn errors of metabolism

  10. Placenta • placental insufficiency • post dates • anatomic • abnormal insertion • hemangiomas • infarcts • abruption

  11. Diagnosis Algorithm IUGR yes TORCH stigmata  work-up? no yes Dysmorphic features  work-up? no

  12. Case # 3 • Infant is delivered at 38 weeks to mom who presents with headaches and epigastric pain • BW: 2.1 kg • HC: 50th%tile • Lt: 30th%tile Pre-eclampsia/ HELLP

  13. Case # 3- What if? • Mom with no prenatal care delivers undiagnosed twins at EGA 34 weeks Discordant twins

  14. Case # 3- What if? • An infant is delivered at 42 weeks via c- section due to NRHTs after induction Post dates • - decreased subcutaneous fat • - skin desquamation • - wizened facies • - large AF(diminished membranous bone formation) • - meconium staining

  15. Diagnosis Algorithm IUGR yes TORCH stigmata  work-up? no yes Dysmorphic features  work-up? no yes Maternal/placental explanation work-up? no

  16. Case # 3- What if? • Infant delivered at EGA 34 weeks to mom with no prenatal care and positive tox screen

  17. Diagnosis Algorithm IUGR yes TORCH stigmata  work-up? no yes Dysmorphic features  work-up? no yes Maternal/placental explanation work-up? no yes Maternal drug use tox screen no Unknown cause

  18. True or False • IUGR infants are prone to asphyxia • True • Why or why not? • Perinatal hypoxia • Chronic and acute • Increased C/S rate, decreased Apgar, increased resuscitation need

  19. An IUGR infant is at risk for Hypothermia? Hypoglycemia? Or Hypocalcemia? decreased subcutaneous fat, increased surface- volume ratio, decreased heat production decreased glycogen stores/ glycogenolysis/ gluconeogenesis increased metabolic rate deficient catecholamine release Associated with perinatal stress, asphyxia, prematurity

  20. Which lab result(s) would not be associated with IUGR? • WBC 4, S8 & B1 • H & H 11/ 33 • Plt 65 • PT 16 • PTT 56 • Direct bilirubin 4.5 • Neutropenia • Polycythemia • Elevated erythropoietin • Thrombocytopenia • Elevated coags • TORCH

  21. Which CxR is more consistent with IUGR? Increased meconium aspiration Decreased surfactant deficiency

  22. Perinatal problems • Perinatal asphyxia • Hypothermia • Hypoglycemia • Hypocalcemia • Polycythemia, hyperviscosity • Thrombocytopenia • Neutropenia • Elevated coags • Decreased surfactant deficiency • Increased meconium aspiration syndrome • Direct hyperbilirubinemia

  23. Evaluation and Management • Physical exam • Labs - blood sugar - urine shell vial (CMV) - calcium - viral cultures (HSV) - CBC diff/plt - syphilis w/u - bilirubin - tox screen - head ultrasound - chromosomes - total IgM vs specific

  24. Quick algorithm

  25. Evaluation and Management • Monitor postnatal weight gain/ head growth • needs may exceed 100-120 cal/kg/d • catch- up by 6-12 months • Hypersomatotropism- accelerated growth velocity • ? Safety of aggressive feeding • rapid weight gain may predispose to childhood obesity highest risk for developing type 2 DM

  26. IUGR- Outcome • Neurodevelopment • etiology and adverse event dependent • lower intelligence, learning/ behavioral disorders, neurologic handicaps • symmetric, chromosomal disorders, congenital infections--- poorer outcome • school performance influenced by social class

  27. World’s smallest…..

More Related